Melissa McKirdy Hazen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vestibular Diseases | 1 | 2021 | 230 | 0.640 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 269 | 0.510 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2021 | 781 | 0.500 |
Why?
|
Immunologic Deficiency Syndromes | 5 | 2019 | 547 | 0.490 |
Why?
|
Rheumatology | 3 | 2023 | 615 | 0.400 |
Why?
|
Macrophage Activation Syndrome | 3 | 2022 | 124 | 0.380 |
Why?
|
Arthritis, Rheumatoid | 5 | 2023 | 3763 | 0.250 |
Why?
|
Homeodomain Proteins | 3 | 2020 | 2416 | 0.230 |
Why?
|
Synovial Fluid | 2 | 2021 | 393 | 0.190 |
Why?
|
Lung Diseases | 2 | 2023 | 1909 | 0.190 |
Why?
|
Autoimmunity | 3 | 2019 | 1356 | 0.180 |
Why?
|
Mannosidase Deficiency Diseases | 1 | 2019 | 3 | 0.180 |
Why?
|
alpha-Mannosidase | 1 | 2019 | 20 | 0.170 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.160 |
Why?
|
Eosinophilia | 1 | 2023 | 560 | 0.150 |
Why?
|
Child | 21 | 2023 | 80153 | 0.150 |
Why?
|
Cell Polarity | 1 | 2021 | 637 | 0.150 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2020 | 227 | 0.150 |
Why?
|
Immunoglobulin G | 4 | 2013 | 4544 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.140 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2021 | 3080 | 0.140 |
Why?
|
Vasculitis | 1 | 2020 | 521 | 0.130 |
Why?
|
Rheumatoid Factor | 1 | 2016 | 185 | 0.130 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 664 | 0.130 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2020 | 621 | 0.120 |
Why?
|
Polysaccharides | 2 | 2012 | 1014 | 0.120 |
Why?
|
Major Histocompatibility Complex | 1 | 2016 | 870 | 0.110 |
Why?
|
Biological Products | 1 | 2023 | 914 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1372 | 0.110 |
Why?
|
Th17 Cells | 1 | 2020 | 794 | 0.110 |
Why?
|
Autoantibodies | 3 | 2023 | 2116 | 0.100 |
Why?
|
Periodicity | 1 | 2013 | 348 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1880 | 0.100 |
Why?
|
HLA Antigens | 1 | 2016 | 1328 | 0.090 |
Why?
|
Galactose | 1 | 2012 | 297 | 0.090 |
Why?
|
Membrane Proteins | 1 | 2008 | 7856 | 0.090 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2011 | 87 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1809 | 0.090 |
Why?
|
Child, Preschool | 11 | 2021 | 42230 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 823 | 0.080 |
Why?
|
Arthritis, Experimental | 1 | 2011 | 291 | 0.080 |
Why?
|
Inflammation | 4 | 2022 | 10773 | 0.070 |
Why?
|
Receptors, IgG | 1 | 2011 | 559 | 0.070 |
Why?
|
Humans | 32 | 2023 | 761504 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5796 | 0.060 |
Why?
|
Infant | 8 | 2021 | 36192 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2015 | 1897 | 0.060 |
Why?
|
Fever | 1 | 2013 | 1618 | 0.060 |
Why?
|
Adolescent | 11 | 2022 | 88319 | 0.060 |
Why?
|
Methotrexate | 1 | 2012 | 1719 | 0.060 |
Why?
|
Macrophage Activation | 1 | 2008 | 553 | 0.060 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10194 | 0.060 |
Why?
|
Glycosylation | 2 | 2019 | 1098 | 0.050 |
Why?
|
Quality Improvement | 2 | 2019 | 3801 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9606 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
Female | 20 | 2022 | 392644 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
Hypertension, Pulmonary | 1 | 2013 | 1578 | 0.050 |
Why?
|
Pain Measurement | 2 | 2022 | 3550 | 0.050 |
Why?
|
Heterozygote | 1 | 2008 | 2787 | 0.050 |
Why?
|
Lung | 1 | 2019 | 10000 | 0.050 |
Why?
|
Consensus | 2 | 2022 | 3123 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4352 | 0.040 |
Why?
|
Male | 17 | 2022 | 360804 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2023 | 1248 | 0.040 |
Why?
|
Pilot Projects | 2 | 2022 | 8631 | 0.040 |
Why?
|
Killer Cells, Natural | 1 | 2008 | 2200 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 422 | 0.040 |
Why?
|
Neutrophils | 1 | 2011 | 3767 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2020 | 584 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 974 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11903 | 0.040 |
Why?
|
Interferon Type I | 1 | 2020 | 562 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2021 | 1870 | 0.030 |
Why?
|
Th1 Cells | 1 | 2021 | 1036 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2020 | 921 | 0.030 |
Why?
|
Glycogen Storage Disease Type IV | 1 | 2015 | 7 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3826 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 536 | 0.030 |
Why?
|
Lymphangiectasis | 1 | 2015 | 20 | 0.030 |
Why?
|
Patient Transfer | 1 | 2022 | 794 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1175 | 0.030 |
Why?
|
Alleles | 2 | 2016 | 6863 | 0.030 |
Why?
|
Genetic Complementation Test | 1 | 2015 | 554 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 80636 | 0.030 |
Why?
|
Cryopyrin-Associated Periodic Syndromes | 1 | 2013 | 17 | 0.030 |
Why?
|
Mevalonate Kinase Deficiency | 1 | 2013 | 19 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2020 | 0.030 |
Why?
|
Catalysis | 1 | 2015 | 774 | 0.030 |
Why?
|
CD40 Ligand | 1 | 2015 | 522 | 0.030 |
Why?
|
Quality Indicators, Health Care | 1 | 2023 | 1792 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21353 | 0.030 |
Why?
|
Stomatitis, Aphthous | 1 | 2013 | 51 | 0.030 |
Why?
|
Hereditary Autoinflammatory Diseases | 1 | 2013 | 42 | 0.030 |
Why?
|
Familial Mediterranean Fever | 1 | 2013 | 65 | 0.030 |
Why?
|
Young Adult | 4 | 2022 | 59243 | 0.030 |
Why?
|
Patient Participation | 1 | 2022 | 1444 | 0.030 |
Why?
|
Knee Joint | 1 | 2021 | 1676 | 0.030 |
Why?
|
Lymphadenitis | 1 | 2013 | 99 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2013 | 256 | 0.030 |
Why?
|
Cost of Illness | 1 | 2022 | 1936 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1723 | 0.020 |
Why?
|
Colchicine | 1 | 2013 | 259 | 0.020 |
Why?
|
Pharyngitis | 1 | 2013 | 219 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 22176 | 0.020 |
Why?
|
Accreditation | 1 | 2014 | 473 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2015 | 2748 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2013 | 585 | 0.020 |
Why?
|
Receptor Cross-Talk | 1 | 2011 | 116 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3208 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1718 | 0.020 |
Why?
|
Hypersensitivity | 1 | 2019 | 1171 | 0.020 |
Why?
|
Homozygote | 1 | 2015 | 1776 | 0.020 |
Why?
|
Ubiquitin | 1 | 2015 | 839 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2449 | 0.020 |
Why?
|
Cold Temperature | 1 | 2013 | 785 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16591 | 0.020 |
Why?
|
Synovitis | 1 | 2011 | 217 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4758 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29625 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4369 | 0.020 |
Why?
|
Adult | 6 | 2020 | 221177 | 0.020 |
Why?
|
Inpatients | 1 | 2020 | 2548 | 0.020 |
Why?
|
Prednisone | 1 | 2013 | 1563 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2011 | 390 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2011 | 819 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3849 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1802 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4580 | 0.020 |
Why?
|
Mutation | 2 | 2013 | 30052 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6766 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4398 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2015 | 1858 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3688 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1217 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2414 | 0.020 |
Why?
|
NF-kappa B | 1 | 2015 | 2490 | 0.020 |
Why?
|
Amyloidosis | 1 | 2013 | 817 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3305 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4174 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5073 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2015 | 2571 | 0.020 |
Why?
|
Monocytes | 1 | 2015 | 2570 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10508 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12725 | 0.020 |
Why?
|
Phagocytosis | 1 | 2011 | 1528 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7967 | 0.020 |
Why?
|
Fibroblasts | 1 | 2015 | 4141 | 0.010 |
Why?
|
Middle Aged | 5 | 2020 | 220895 | 0.010 |
Why?
|
Cytokines | 1 | 2019 | 7396 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12974 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2016 | 26125 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15732 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2015 | 13446 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2273 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2011 | 2693 | 0.010 |
Why?
|
Family | 1 | 2013 | 3194 | 0.010 |
Why?
|
Genotype | 1 | 2016 | 12990 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7390 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2244 | 0.010 |
Why?
|
Curriculum | 1 | 2014 | 3743 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5671 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 18965 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10723 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2013 | 4936 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8654 | 0.010 |
Why?
|
Cohort Studies | 2 | 2013 | 41487 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17904 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14031 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39106 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15936 | 0.010 |
Why?
|
Registries | 1 | 2013 | 8224 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10552 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20570 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 74206 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15266 | 0.010 |
Why?
|
Transcription Factors | 1 | 2015 | 12128 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14414 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36426 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2011 | 22169 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15842 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 64680 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2011 | 18252 | 0.010 |
Why?
|
United States | 1 | 2019 | 72334 | 0.010 |
Why?
|
Mice | 1 | 2011 | 81525 | 0.000 |
Why?
|
Aged | 1 | 2012 | 169289 | 0.000 |
Why?
|
Animals | 1 | 2011 | 168459 | 0.000 |
Why?
|